Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer
2007

Anemia in Breast Cancer Patients Undergoing Chemotherapy

Sample size: 702 publication Evidence: moderate

Author Information

Author(s): Goldrick A. MD, Olivotto I.A. MD, Alexander C.S. CCHRA(C), Speers C.H. BA CCHRA(C), Barnett J. BSc (Pharm) MSc, Allan S.J. MD, Truong P.T. MDCM

Primary Institution: BC Cancer Agency

Hypothesis

What is the frequency and severity of anemia during adjuvant chemotherapy for breast cancer?

Conclusion

Anemia is common among breast cancer patients receiving chemotherapy, but discussions and interventions for anemia are infrequent.

Supporting Evidence

  • 78% of patients had at least one hemoglobin reading <120 g/L.
  • 54% of patients had at least one hemoglobin reading <110 g/L.
  • 31% of patients had at least one hemoglobin reading <100 g/L.
  • 14% of patients had at least one hemoglobin reading <90 g/L.
  • Intervention rates increased as hemoglobin declined.

Takeaway

Many women getting treatment for breast cancer become anemic, but doctors often don't talk about it or help fix it.

Methodology

Retrospective electronic chart review of 702 patients who received adjuvant chemotherapy at four BC Cancer Agency centres.

Potential Biases

Potential underreporting of discussions and interventions for anemia in patient charts.

Limitations

The study did not record the magnitude of fatigue or quality of life effects, and some patients may not have been symptomatic.

Participant Demographics

Median age of participants was 51 years; 12% had a hemoglobin reading <120 g/L before chemotherapy.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication